Search
for
Sort by
Research 61–90 of 1000+
- Bioassay-guided isolation of two antiproliferative metabolites from Pterocarpus indicus Willd. against TGF-β-induced prostate stromal cells (WPMY-1) proliferation via PI3K/AKT signaling pathway
- Mitigating Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Ameliorating Sexual Function and Psychological Well-Being in Older Men
- Is there a relationship between androgenic alopecia and benign prostatic hyperplasia?
- Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
- Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia was Confirmed by Clinical Trial
- Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- 1746 INCREASED SERUM C-REACTIVE PROTEIN LEVELS IMPLIES CHRONIC INFLAMMATION IS INVOLVED IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PREDOMINANT STORAGE LOWER URINARY TRACT SYMPTOMS
- 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?
- Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy
- Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- Contrast-Enhanced Ultrasound (CEUS) Evaluation of Canine Prostatic Hyperplasia before and after Osaterone Acetate Therapy: Preliminary Results
- Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States